search

All clinical trials

Results 461421-461430 of 470744

Neuropsychiatry and Cognition in SCA3/MJD

Spinocerebellar Ataxia Type 3Machado-Joseph Disease2 more

This research investigates how cognitive-affective aspects evolve during the course of SCA3/MJD. Due to COVID-19 pandemics, this study protocol was adapted for online-only consultations. Evaluations happening after March 2020 have been done by videocall with patients, and no neurological evaluation was thus performed on these patients. A scale on Activities of Daily Living was added to the online protocol to replace SARA, SCAFI and CCFS scales.

Unknown status13 enrollment criteria

Asphyxia Associated Metabolite Biomarker Investigation 2

Birth Asphyxia

Follow-up of participants of AAMBI1 study at age of at least 2 years. AAMBI1(ClinicalTrials.gov ID: NCT03354208): Verification of biomarkers in a human population for their ability to diagnose the severity of neonatal asphyxia. These biomarkers linked to asphyxia have been identified in animal studies.

Unknown status2 enrollment criteria

Gait Analysis in Females Suffering From Patellofemoral Pain Syndrome (PFPS)

Patellofemoral Pain Syndrome

The purpose of the study was to evaluate the spatial and temporal variables during walking cycle in adolescent females suffering from patellofemoral pain syndrome (PFPS) versus healthy adolescent females .

Unknown status2 enrollment criteria

Bone Metastases in neurOendocrine NEoplasms: naTural History, Prognostic Impact and Therapeutic...

Bone MetastasesNeuroendocrine Neoplasm

This is a retrospective/prospective observational multicentric trial on patients with bone metastases from NENs. General objectives: To trace on a national scale the frequency of bone metastases in patients with neuroendocrine neoplasm (NEN) and their clinical management. To correlate clinical and biological factors to clinical outcomes. To centralise and to make homogeneous clinical, pathological, instrumental and therapeutic information. To set up a database and to acquire biological material for studying predictive and prognostic biomarkers.

Unknown status6 enrollment criteria

Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve

Diminished Ovarian Reserve

The study aims to explore the genetic pathogenesis of diminished ovarian reserve via whole-genome sequencing technology in Chinese women.

Unknown status14 enrollment criteria

Epidemiology of Abnormal Vaginal Discharge During Pregnancy

Vaginal Infection

Vaginitis among women of childbearing age is well acknowledged as a public health concern due to its high occurrence. Vulvovaginitis is a disorder of the vulva and/or vagina caused by infection, inflammation, or changes in the flora. There are many types of infections that affect the vagina, the most common three types of infection: bacterial vaginosis, trichomoniasis, and candidiasis. Bacterial vaginosis is the most common vaginal infection in women of reproductive age causing thin and milky vaginal discharge with a fishy odor. Trichomoniasis causes a frothy, greenish-yellow discharge with a foul smell. Vaginal Candidiasis is one of the most common fungal infections of the female genital tract and the second most common vaginal infection affecting women of reproductive age (after the bacterial infection worldwide. It affects more than 75% of women at least once in their lifetime, with approximately 50% of them also suffering a single recurrence. About 75% of patients suffering from candidiasis are asymptomatic, but it may be symptomatic with clinical picture characterized by itching, vaginal pain, vulvar burning sensation, dyspareunia, dysuria and mildly unpleasant odor, erythema and vulvar edema, white-yellowish plaques on the walls of the vagina and cervix and cheesy vaginal discharge. The risk of vulvo-vaginal candidiasis increases by 30% during pregnancy also in pregnancy, the presence of vaginitis is related to abortion, intrauterine infection, fetal growth retardation, premature rupture of membranes, preterm birth, low birth weight, puerperal infection, and other adverse pregnancy outcomes.

Unknown status7 enrollment criteria

Frequency and Causes of Failed Endoscopic Retrograde Cholangio-Pancreatography in AL-Rajhi Endoscopy...

ERCPFailure2 more

The failure can be traced backed to operator causes, technical causes and patient causes. the most common etiology is cannulation failure. ERCP complications includes post-ERCP pancreatitis, perforation, bleeding, cholangitis and cholecystitis.

Unknown status2 enrollment criteria

The Biomarker Exploratory Study in Prospective Multicenter Observational Study of Atezolizumab Combination...

Non-small Cell Lung CancerExtensive Disease Small Cell Lung Cancer

This study is implemented in association with the study "J-TAIL-2" ; prospective multicenter observational study of atezolizumab in patients with unresectable, locally advanced or metastatic non-small cell lung cancer, UMIN study ID: UMIN000041263, to evaluate biomarkers for selection of appropriate patients in treatment with atezolizumab combination therapy.

Unknown status15 enrollment criteria

Anti COVID-19 Antibodies in Follicular Fluid and Spermatic Fluid

SARS-CoV-2

Patients going through an in vitro fertilization cycle will be asked to participate . Patients will be asked for their COVID-19 exposure : post confirmed disease/post vaccine/not exposed to disease or vaccine . Patients will provide the fluids which are not required , once fertilization process is completed. Patients will also provide 5ml blood sample by the day of procedure. Anti COVID-19 immunoglobulin G type antibodies will be measured in all samples . Data regarding age, date of infection/vaccine will be collected . Progesterone and Estrogen will be measured in female patients' samples and Perlecan level will be measured in follicular fluid.

Unknown status5 enrollment criteria

Pan-canceR Early-Stage deteCtion by lIquid Biopsy tEchNique projecT

Cancer

PRESCIENT is a multi-center, prospective observational study aimed to detect cancers early by combined assays for serum protein markers and cell-free DNA (cfDNA) methylation markers. Blood RNA markers will also be evaluated. The study will enroll approximately 11879 participants, including participants with malignancies or benign diseases, and healthy participants.

Unknown status24 enrollment criteria
1...461424614346144...47075

Need Help? Contact our team!


We'll reach out to this number within 24 hrs